Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study.

Authors

null

Raksha Dutt

University of California San Diego, San Diego, CA

Raksha Dutt , Margaret Frances Meagher , Dattatraya Patil , Kazutaka Saito , Devin Patel , Fady Ghali , Cathrine Keiner , Nathan Miller , Aaron Bradshaw , Fang Wan , Yosuke Yasuda , Yasuhisa Fujii , Viraj A. Master , Ithaar Derweesh

Organizations

University of California San Diego, San Diego, CA, Emory University School of Medicine, Atlanta, GA, Tokyo Medical and Dental University, Tokyo, Japan, UC San Diego, Department of Urology, San Diego, CA, UC San Diego Moores Cancer Center, San Diego, CA, Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan, Winship Cancer Institute of Emory University, Atlanta, GA

Research Funding

No funding received
None.

Background: Functional decline is an important consideration in the surgical treatment of renal cell carcinoma (RCC). While radical nephrectomy (RN) may be associated with increased risk of functional decline compared to partial nephrectomy (PN), the modifying effect of DM, an independent risk factor of chronic kidney disease (CKD), is not completely understood. We investigated the relationship between DM and decline in kidney function following surgery for RCC, and impact on overall survival (OS) in patients with RCC. Methods: A multicenter dataset of RCC patients undergoing PN and RN was utilized. The cohort was divided based on DM status [DM vs No DM (NDM)]. Multivariable analysis (MVA) elucidated potential variables associated with decline in kidney function [de novo estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73m2 and de novo eGFR < 30 ml/min/1.73m2] and worse all-cause mortality (ACM). Kaplan-Meier analysis (KMA) was used to investigate OS rates in DM and NDM patients undergoing RN and PN. Results: 2928 patients were analyzed (DM = 406, NDM = 2522). On MVA, independent risk factors associated with eGFR < 45 included age (OR = 1.07, p < 0.001), DM (OR = 1.88, p < 0.001), tumor size (OR = 1.03, p = 0.032), and RN (OR = 1.54, p < 0.001). Variables associated with eGFR < 30 included age (OR = 1.05, p < 0.001), African American race (OR = 2.18, p < 0.001), and DM (OR = 2.09, p < 0.001). MVA for ACM revealed age (OR = 1.02, p = 0.002), HTN (OR = 2.47, p < 0.001), tumor size (OR = 1.12, p < 0.001), tumor grade (OR = 1.87, p < 0.001), RN (OR = 1.55, p = 0.011), eGFR < 45 (OR = 1.40, p = 0.03), and eGFR < 30 (OR = 1.87, p = 0.026) to be independently associated. On KMA, 5-year OS stratified by DM status showed that DM is associated with worse OS for RN patients (p = 0.047), but not for PN patients (p = 0.944). Conclusions: Presence of DM is an independent risk factor for renal functional decline and development of worsening CKD is a risk factor for worsening ACM. Furthermore, decreased survival in DM patients was associated with RN recipients but not with PN recipients. Presence of DM may be considered a strong indicator for nephron preservation management strategies when safe and feasible in RCC patients.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Quality of Care/Quality Improvement

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 666)

Abstract #

666

Poster Bd #

F8

Abstract Disclosures

Similar Abstracts

Abstract

2022 ASCO Genitourinary Cancers Symposium

Does presence of diabetes mellitus impact patient oncological outcomes in renal cell carcinoma: A multicenter analysis.

First Author: Ava Saidian

First Author: Ryan Nasseri

First Author: Maxwell Sandberg